IMPRI and Separations Partnership Powers Breakthroughs in Biomedical Imaging
- FHS Communications
IMPRI, has partnered with Promolab (Pty) Ltd T/A Separations
The University of the Witwatersrand, Johannesburg (Wits University), through its Faculty of Health Sciences and the Integrated Molecular Physiology Research Initiative (IMPRI), has partnered with Promolab (Pty) Ltd T/A Separations to advance biomedical imaging capabilities in Africa. This collaboration marks a significant milestone in bridging the gap between basic science and clinical application, particularly in the study of non-communicable diseases.
This strategic alliance has enabled the deployment of the Leica Microsystems THUNDER Imaging System at Wits University, providing researchers and postgraduate students with access to cutting-edge, globally recognised imaging technology. The initiative underscores the Faculty’s commitment to advancing scientific excellence, innovation, and capacity building in health sciences research.
IMPRI is a cutting-edge research initiative that utilises advanced molecular physiology techniques to bridge the translational divide—the gap between laboratory discoveries and their clinical application. Its overarching goal is to deepen understanding of the molecular mechanisms underlying neurological, mental-health-related, and cardiometabolic disorders, which are among the most pressing contributors to the global public healthcare burden.
“To ensure that African research is globally competitive, it is important to build state-of-the-art research infrastructure,” says Associate Professor Sooraj Baijnath, Co-Director of IMPRI.
Leica Microsystems THUNDER Imaging System will provide researchers and postgraduate students with access to world-class imaging technology. This system enables:
- Live-cell imaging to observe dynamic biological processes in real time.
- Thick tissue imaging without sectioning, preserving sample integrity.
- 3D reconstruction of complex biological structures for spatial analysis.
- Low phototoxicity and high-speed acquisition, ideal for long-term studies and sensitive samples.
These capabilities will be used in IMPRI’s research projects, which span various pathophysiological and therapeutic aspects of non-communicable diseases.
“At Separations, we believe African researchers should not only participate in but lead global scientific innovation. This collaboration with Wits University is a tangible step towards that future,” said Nicolas Queisser, Managing Director of Separations.